Patent Yard Sign in
Canadian application, no grantCanada

A method for treating inflammatory diseases by administering a ppar-delta agonist

CA 2449247 A1 · Owner: Forrest, Michael J. · Inventors: Forrest, Michael J.; Berger, Joel P.; Wright, Samuel

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A method for treating, controlling, preventing or reducing the risk of contracting an inflammatory disease or condition in a mammalian patient comprises the steps of (1) selecting a patient in need thereof and (2) , treating the patient with a therapeutically effective amount of a composition comprising a PPAR-.delta. agonist. Inflammatory diseases that may be treated by this method include but are not limited to rheumatoid arthritis juvenile , rheumatoid arthritis, systemic lupus erythematosus osteoarthritis, degenerative joint disease one or more connective tissue diseases ankylosing , spondylitis, and bursitis.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 7, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 7, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 7, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 7, 2002
GrantedNo grant recorded
Term endedJune 7, 2022
Patent numberCA 2449247 A1
Classification (IPC)A61K31/50 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedJune 7, 2002Term endedJune 7, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.